-
公开(公告)号:US20080063753A1
公开(公告)日:2008-03-13
申请号:US11851473
申请日:2007-09-07
申请人: Normanella DeWille , Judith Atkinson , Neile Edens , Terrence Mazer , Kelley Lowe , Douglas Wearly , Allison Ogilvie
发明人: Normanella DeWille , Judith Atkinson , Neile Edens , Terrence Mazer , Kelley Lowe , Douglas Wearly , Allison Ogilvie
CPC分类号: A23L7/126 , A23L7/122 , A23P20/12 , A23P20/18 , A23P20/20 , A23V2002/00 , A23V2200/22 , A23V2200/328 , A23V2250/606
摘要: The present invention provides a food product comprising: a formed reduced glycemic response cereal component; and a non-sticky reduced glycemic response sweetener coating over the formed cereal component, the sweetener coating comprising: a first sticky layer comprising at least about 30% fructose (of the total sweetener coating); a second less sticky layer having a DE value of about 60 or less and comprising up to about 17% fructose and at least about 1% non-fructose carbohydrates (of the total sweetener coating); and third layer comprising crystalline fructose. The present invention also provides a process for forming the sweetener coating over the formed cereal component comprising the following steps: (a) providing a formed cereal component having thereon a first sticky layer comprising fructose; (b) forming over the first sticky layer a less stick second layer comprising non-fructose carbohydrates and optionally fructose; and (c) applying crystalline fructose over the second layer.
摘要翻译: 本发明提供一种食品,其包含:形成的降低的血糖反应谷物成分; 和在形成的谷物成分上的非粘性降低的血糖响应甜味剂涂层,所述甜味剂涂层包含:包含至少约30%的果糖(总甜味剂包衣的)的第一粘性层; DE值为约60或更小的第二较低粘性层,包含高达约17%的果糖和至少约1%的非果糖碳水化合物(总甜味剂涂层); 和包含结晶果糖的第三层。 本发明还提供了一种用于在所形成的谷物成分上形成甜味剂涂层的方法,包括以下步骤:(a)提供形成有谷物成分的谷物成分,其上含有果糖的第一粘性层; (b)在第一粘性层上形成较少的第二层,其包含非果糖碳水化合物和任选的果糖; 和(c)在第二层上施加结晶果糖。
-
2.
公开(公告)号:US20070048405A1
公开(公告)日:2007-03-01
申请号:US11485709
申请日:2006-07-13
IPC分类号: A23L1/30
CPC分类号: A23L1/3008 , A23C11/04 , A23L2/52 , A23L27/13 , A23L33/12 , A23L33/19 , A23V2002/00 , A23V2200/30 , A23V2250/54252 , A23V2250/1882 , A23V2200/16
摘要: Disclosed are liquid nutritional compositions comprising: carbohydrate; lipid having from about 0.1% to about 20% of an n-3 polyunsaturated fatty acid, n-6 polyunsaturated fatty acid, or combinations thereof by weight of the composition; a protein matrix having from about 15% to about 50% of a whey protein fraction by weight of the total protein in the composition; and a limonene-containing material, cranberry oil, or combinations thereof. The compositions are preferably aseptically packaged, and provide enhanced oxidative stability, flavor, and aroma, especially when formulated with relative high polyunsaturated fatty acid concentrations.
摘要翻译: 公开了液体营养组合物,其包含:碳水化合物; 具有约0.1%至约20%的n-3多不饱和脂肪酸,n-6多不饱和脂肪酸或其组合的重量的组合物的脂质; 蛋白质基质,其占组合物中总蛋白重量的约15%至约50%的乳清蛋白级分; 和含柠檬烯的材料,蔓越莓油或其组合。 组合物优选无菌包装,并且提供增强的氧化稳定性,风味和香气,特别是当用相对高的多不饱和脂肪酸浓度配制时。
-
公开(公告)号:US20060034944A1
公开(公告)日:2006-02-16
申请号:US11117236
申请日:2005-04-28
申请人: Keith Rushlow , Robert Shalwitz , Terrence Mazer , Normanella Dewille , Tapas Das , Anand Seth
发明人: Keith Rushlow , Robert Shalwitz , Terrence Mazer , Normanella Dewille , Tapas Das , Anand Seth
IPC分类号: A61K36/30 , A61K36/064 , A61K31/202 , A61K31/198 , A61K33/04
CPC分类号: A61K36/30 , A23L33/12 , A23L33/15 , A23L33/165 , A23L33/40 , A23V2002/00 , A61K31/198 , A61K31/202 , A61K33/04 , A61K36/064 , A61K2300/00 , A23V2250/5424 , A23V2250/1578 , A23V2250/1882 , A23V2250/1842 , A23V2250/1598 , A23V2200/308 , A23V2250/714 , A23V2250/7106 , A23V2250/712 , A23V2250/1874
摘要: Disclosed are compositions and corresponding methods for treating fibrocystic breast disease or other breast-related disease or condition. The compositions comprise, per serving or dose, from zero to about 400 μg selenium, from about 100 mg to about 6000 mg gamma linolenic acid, and about 0.15 mg to about 5 mg iodine, with nutritional embodiments further comprising one or more of protein, fat, carbohydrate, vitamins, and minerals and providing from about 50 to about 1000 kcal of energy per severing or dose. Also disclosed are in-vitro studies showing that certain combinations of gamma linolenic acid, iodine, and/or selenium may 1) inhibit breast cancer or fibrocystic cell proliferation, 2) reinforce the function of tight junctions of endothelial cells and of mammary epithelial cells in estrogen-sensitive conditions, and 3) reduce the risk of vascular invasion by breast cancer cells.
摘要翻译: 公开了治疗纤维囊性乳腺疾病或其它乳腺相关疾病或病症的组合物和相应的方法。 该组合物每份或剂量包含从0至约400杯硒,约100mg至约6000mgγ亚麻酸和约0.15mg至约5mg的碘,营养实施方案还包含一种或多种蛋白质, 脂肪,碳水化合物,维生素和矿物质,并且每切断或剂量提供约50至约1000千卡的能量。 还公开了体外研究,显示γ亚麻酸,碘和/或硒的某些组合可以1)抑制乳腺癌或纤维囊性细胞增殖,2)增强内皮细胞和乳腺上皮细胞紧密连接的功能 雌激素敏感条件,以及3)降低乳腺癌细胞血管侵袭的风险。
-
-